Syndax Pharmaceuticals Inc (SNDX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.29 | +11.6% |
| 2024 | $-3.72 | -24.8% |
| 2023 | $-2.98 | -21.1% |
| 2022 | $-2.46 | -634.8% |
| 2021 | $0.46 | +124.6% |
| 2020 | $-1.87 | -1.6% |
| 2019 | $-1.84 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.29 | +11.6% |
| 2024 | $-3.72 | -24.8% |
| 2023 | $-2.98 | -21.1% |
| 2022 | $-2.46 | -634.8% |
| 2021 | $0.46 | +124.6% |
| 2020 | $-1.87 | -1.6% |
| 2019 | $-1.84 | — |